ENHANCEMENT OF ANTITUMOR RESPONSE TO SARCOMA 45 IN RATS BY COMBINATION OF WHOLE-BODY HYPERTHERMIA AND INTERLEUKIN-2
Michael P. Potapnev1,*, Yuri P. Istomin2, Reiman S. Ismail-zade1, Edvard A. Zhavrid2
1Research Department, Belarussian Research Center for Pediatric Oncology & Hematology, P.O. Lesnoy, Minsk BE-223052, Belarus 2N.N. Alexandrov Research Institute of Oncology & Medical Radiology, P.O. Lesnoy-2, 223040 Minsk, Belarus
Abstract. Aim: To evaluate the summarized effect of hyperthermia and interleukin-2 (IL-2) administration on antitumor defense in tumor-bearing rats. Methods: Nonbred rats after subcutaneous inoculation of sarcoma 45 cells were treated with whole-body hyperthermia (WBH, +42.5 оС, 60 min) and interleukin-2 (IL-2, 10 000 U/kg of body weight). Parameters of tumor growth and survival of animals were monitored till day 33 after tumor cell inoculation. Results: Combined application of WBH and IL-2 at 5th day after tumor cell transplantation resulted in a delay of tumor growth and improvement of survival parameters in comparison with control group or animals that received separate treatment. Therapeutic efficacy of WBH combined with IL-2 was analogous to a single-dose chemotherapy with cyclophosphamide. Conclusion: Combined application of WBH and IL-2 is the useful approach for cancer immunotherapy.